alpha-Cedrene

N/A

Report date: 2025/06/05 16:57:45
NME

Base Information

Drug Namealpha-Cedrene
Drug Alias NameKD-101
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKwang-Dong
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDrug-Related Side Effects and Adverse ReactionsObesity

Other Information

ATC CodeN/A
Related LinksN/A